Ethyl 5,7-Difluoro-1H-Indole-2-Carboxylate Bulk Price 2026: Market Analysis & Procurement Guide
- [Synthetic Pathway] Optimized manufacturing process ensures consistent reaction yields and minimal impurity profiles for downstream API synthesis.
- [Procurement Stability] Factory-direct sourcing eliminates intermediary markups, securing reliable tonnage quantities and FOB terms for global logistics.
- [Market Valuation] 2026 pricing models reflect raw material volatility adjustments, offering cost-effective solutions for long-term commercial contracts.
As the pharmaceutical landscape evolves toward complex fluorinated intermediates, securing a stable supply chain for key building blocks becomes paramount. Ethyl 5,7-Difluoro-1H-Indole-2-Carboxylate (CAS: 220679-10-7) represents a critical scaffold in the development of kinase inhibitors and oncology therapeutics. For procurement officers and technical directors planning budgets through 2026, understanding the interplay between industrial purity standards and volume-based pricing tiers is essential for maintaining margin integrity.
At NINGBO INNO PHARMCHEM CO.,LTD., we specialize in scaling production from kilogram to multi-ton batches without compromising on chemical consistency. This guide details the technical specifications, synthesis viability, and commercial forecasting necessary for strategic sourcing of this high-value intermediate.
Technical Synthesis and Impurity Control
For process chemists and R&D leads, the viability of this intermediate hinges on the robustness of the synthesis route. The production of 5,7-Difluoroindole-2-carboxylic acid ethyl ester typically involves the cyclization of fluorinated aniline derivatives followed by esterification. Our manufacturing process utilizes advanced catalytic systems to maximize reaction yields while suppressing common side products such as regioisomers or over-fluorinated byproducts.
Batch-to-batch consistency is verified through rigorous HPLC and NMR analysis. Achieving >98% assay purity is standard for our commercial grade output, ensuring that downstream coupling reactions proceed without extensive purification steps. This level of industrial purity reduces solvent waste and processing time, directly impacting the cost of goods sold (COGS) for the final active pharmaceutical ingredient.
Volume-Based Pricing and Supply Chain Security
When evaluating the bulk price for 2026, buyers must consider the total cost of ownership, which includes logistics, customs, and quality verification. Small-scale research suppliers often list premium rates for gram quantities, which do not reflect true production costs at scale. Transitioning to a global manufacturer with dedicated production lines allows for significant cost reductions per kilogram.
Our pricing structure is tiered to accommodate various stages of development:
- Clinical Trial Batches: Flexible quantities from 10kg to 100kg with expedited lead times.
- Commercial Production: Ton-scale contracts with locked-in pricing agreements to hedge against raw material fluctuation.
- Logistics: FOB terms available from major Chinese ports, with comprehensive documentation for seamless customs clearance.
When sourcing high-purity Ethyl 5,7-Difluoro-1H-indole-2-carboxylate, buyers should prioritize suppliers who can provide immediate access to batch-specific documentation. Reliability in supply chain continuity is just as critical as the unit price, especially for long-term API manufacturing roadmaps.
Quality Parameters and Regulatory Compliance
Executive decision-makers must ensure that all procured materials meet international regulatory standards, including REACH and TSCA compliance where applicable. Our facility adheres to strict ISO quality management systems, ensuring that every shipment is accompanied by a comprehensive COA (Certificate of Analysis) and Safety Data Sheet (SDS).
The table below outlines the standard technical specifications for our commercial production runs:
| Parameter | Specification |
|---|---|
| CAS Registry Number | 220679-10-7 |
| Molecular Formula | C11H9F2NO2 |
| Molecular Weight | 225.19 g/mol |
| Assay Purity (HPLC) | ≥ 98.0% |
| Appearance | Off-white to Light Yellow Solid |
| Storage Conditions | Sealed in dry, Room Temperature |
| Packaging | 25kg Fiber Drums or Custom Bulk Bags |
Strategic Procurement for 2026
Market analysis indicates a steady increase in demand for fluorinated indole derivatives driven by oncology pipeline expansions. Locking in supply contracts now mitigates the risk of capacity constraints in 2026. NINGBO INNO PHARMCHEM CO.,LTD. maintains significant reserve capacity to handle urgent scale-up requests, ensuring that your production schedules remain uninterrupted.
We recommend initiating qualification batches early to validate performance in your specific synthetic sequences. Our technical team is equipped to support custom synthesis modifications if specific impurity profiles need further suppression.
To secure your supply chain and optimize costs, contact our technical sales team for a batch-specific COA, SDS, or bulk pricing quote.